Retatrutide 60mg Multi Dose Pen by Dragon Pharma is coming soon.

[Anabolix]

Retatrutide 60mg Multi Dose Pen by Dragon Pharma is coming soon​

We’re pleased to introduce an upcoming addition to the Dragon Pharma research portfolio: Retatrutide.​

Designed around advanced metabolic research, Retatrutide is described as a triple agonist involving GLP-1, GIP, and glucagon receptors, making it an important compound within ongoing research into metabolic pathways, energy regulation, appetite signaling, and glucose metabolism.

What Makes Retatrutide Interesting?​

Retatrutide has attracted significant scientific interest because of its multi-receptor mechanism. Rather than focusing on a single metabolic pathway, research surrounding this compound examines the combined activity of three receptor systems:

• GLP-1 — involved in glucose regulation and appetite-related signaling
• GIP — associated with metabolic and insulin-related signaling
• Glucagon — involved in energy expenditure and metabolic regulation

The combination of these pathways makes Retatrutide an interesting subject for researchers studying the relationship between metabolism, energy balance, appetite signaling, and glucose homeostasis.

Dragon Pharma Research Presentation​

The upcoming Dragon Pharma Retatrutide presentation has been designed with a focus on professional research standards and product presentation.

The packaging features a dedicated Retatrutide presentation with a multi-dose research pen, clearly identified product information, dosage information, storage guidance, and Dragon Pharma branding.

The objective is to provide researchers with a clearly presented product format suitable for laboratory and scientific research environments.

Product Details​

Product: Retatrutide
Presentation: Multi-dose Dragon Pharma Pen
Total: 60 mg
Configuration: 5 doses of 12 mg
Format: Research-use product

Product packaging and labeling should always be reviewed carefully before handling or storage.

Research Areas​

Research involving Retatrutide may be relevant to investigations surrounding:

• Metabolic signaling pathways
• GLP-1/GIP receptor activity
• Glucagon receptor signaling
• Appetite and energy-balance mechanisms
• Glucose and metabolic regulation
• Multi-receptor pharmacology
• Next-generation metabolic research

As research continues, compounds involving multiple metabolic targets remain an area of substantial scientific interest.

Dragon Pharma​

At Dragon Pharma, our presentation is built around three principles:

RESEARCH / QUALITY / RESULTS

Our goal is to provide clearly identified research products with professional packaging and consistent presentation, while maintaining a strong focus on research-oriented applications.

Coming Soon​

Retatrutide is coming soon to the Dragon Pharma Store.

For product information, availability updates, and future announcements, visit:

www.dragonpharmastore.to

Stay connected for upcoming product announcements and research-focused releases from Dragon Pharma.

---

​